India’s Generic Drug Resilience: 20% Global Market Share, US Tariff Exemption, and the Semaglutide Revolution
India's pharmaceutical industry continues to demonstrate remarkable resilience and global influence in 2026. With the nation supplying approximately 20% of the world's generic medicines, recent developments — including US tariff…
Continue Reading
India’s Generic Drug Resilience: 20% Global Market Share, US Tariff Exemption, and the Semaglutide Revolution